209 related articles for article (PubMed ID: 11002685)
1. Haemostasis with cryoprecipitate in patients undergoing surgery for severe von Willebrand disease.
Mathews V; Srivastava A; Nair SC; Chandy M
Natl Med J India; 2000; 13(4):188-90. PubMed ID: 11002685
[TBL] [Abstract][Full Text] [Related]
2. A perspective on the use of FVIII concentrates and cryoprecipitate prophylactically in surgery or therapeutically in severe bleeds in patients with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
Foster PA
Thromb Haemost; 1995 Nov; 74(5):1370-8. PubMed ID: 8607125
[TBL] [Abstract][Full Text] [Related]
3. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI.
Viswabandya A; Mathews V; George B; Nair SC; Baidya S; Mammen JJ; Chandy M; Srivastava A
Haemophilia; 2008 Jul; 14(4):763-7. PubMed ID: 18445014
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of factor VIII/von Willebrand factor concentrate Alphanate in preventing excessive bleeding during surgery in subjects with von Willebrand disease.
Rivard GE; Aledort L;
Haemophilia; 2008 Mar; 14(2):271-5. PubMed ID: 18194310
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.
Lethagen S; Kyrle PA; Castaman G; Haertel S; Mannucci PM;
J Thromb Haemost; 2007 Jul; 5(7):1420-30. PubMed ID: 17439628
[TBL] [Abstract][Full Text] [Related]
7. Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion.
Frank RD; Kunz D; Wirtz DC
Am J Hematol; 2002 May; 70(1):64-71. PubMed ID: 11994985
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of von Willebrand factor and factor VIII after elective heart surgery in a 12-year-old girl with von Willebrand disease type 3.
Kühne T; Imbach P; Marbet GA; Caliezi C; Devay J
Pediatr Hematol Oncol; 1999; 16(6):551-6. PubMed ID: 10599096
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of von Willebrand-Jürgens syndrome with "hepatitis-free" factor VIII concentrates].
Köhler M; Hellstern P; Reiter B; Miyashita C; von Blohn G; Wenzel E
Dtsch Med Wochenschr; 1984 Nov; 109(47):1800-5. PubMed ID: 6437785
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the bleeding tendency in uremia with cryoprecipitate.
Janson PA; Jubelirer SJ; Weinstein MJ; Deykin D
N Engl J Med; 1980 Dec; 303(23):1318-22. PubMed ID: 6776402
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate) in patients with von Willebrand disorder requiring invasive or surgical procedures.
Shortt J; Dunkley S; Rickard K; Baker R; Street A
Haemophilia; 2007 Mar; 13(2):144-8. PubMed ID: 17286766
[TBL] [Abstract][Full Text] [Related]
12. Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients.
Borel-Derlon A; Federici AB; Roussel-Robert V; Goudemand J; Lee CA; Scharrer I; Rothschild C; Berntorp E; Henriet C; Tellier Z; Bridey F; Mannucci PM
J Thromb Haemost; 2007 Jun; 5(6):1115-24. PubMed ID: 17403090
[TBL] [Abstract][Full Text] [Related]
13. New approach of the treatment of von Willebrand's disease during pregnancy.
Gojnic M; Fazlagic A; Likic I; Stefanovic A; Vidakovic S; Pervulov M; Petkovic S; Mostic T; Miljic P; Bogdanovic A
Arch Gynecol Obstet; 2005 Nov; 273(1):35-8. PubMed ID: 16172853
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease.
Lillicrap D; Poon MC; Walker I; Xie F; Schwartz BA;
Thromb Haemost; 2002 Feb; 87(2):224-30. PubMed ID: 11858481
[TBL] [Abstract][Full Text] [Related]
15. Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate.
Berntorp E; Windyga J;
Haemophilia; 2009 Jan; 15(1):122-30. PubMed ID: 19149848
[TBL] [Abstract][Full Text] [Related]
16. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
[TBL] [Abstract][Full Text] [Related]
17. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
18. Cryoprecipitate-topical thrombin glue. Initial experience in patients undergoing cardiac operations.
Lupinetti FM; Stoney WS; Alford WC; Burrus GR; Glassford DM; Petracek MR; Thomas CS
J Thorac Cardiovasc Surg; 1985 Oct; 90(4):502-5. PubMed ID: 3930885
[TBL] [Abstract][Full Text] [Related]
19. The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome.
Macik BG; Gabriel DA; White GC; High K; Roberts H
Arch Pathol Lab Med; 1988 Feb; 112(2):143-6. PubMed ID: 2447856
[TBL] [Abstract][Full Text] [Related]
20. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
